About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 24, 2011
DDMAC – Unclear Transparency on FDA Social Media Guidance
For many years now, there has been a long wait after a public hearing held in 1996 on some form of guidance from the FDA that would provide communications guidelines for this new medium. Fifteen years have passed and those … Continue reading
Posted in FDA Image, FDA Policy
Comments Off on DDMAC – Unclear Transparency on FDA Social Media Guidance